These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30738186)

  • 21. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
    Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
    Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.
    Diel R; Loddenkemper R; Nienhaus A
    Chest; 2012 Jul; 142(1):63-75. PubMed ID: 22490872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.
    Adams JW; Howe CJ; Andrews AC; Allen SL; Vinnard C
    AIDS Care; 2017 Dec; 29(12):1504-1509. PubMed ID: 28486818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test.
    He Y; Cao X; Guo T; He Y; Du Y; Zhang H; Feng B; Du J; Zhang B; Wang K; Yan J; Wang D; Liu Z; Pan S; Xin H; Gao L
    Front Public Health; 2022; 10():1025550. PubMed ID: 36530654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection.
    De Keyser E; De Keyser F; De Baets F
    Acta Clin Belg; 2014 Oct; 69(5):358-66. PubMed ID: 25018132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.
    Machingaidze S; Wiysonge CS; Gonzalez-Angulo Y; Hatherill M; Moyo S; Hanekom W; Mahomed H
    Pediatr Infect Dis J; 2011 Aug; 30(8):694-700. PubMed ID: 21427627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.
    Goletti D; Sanduzzi A; Delogu G
    J Rheumatol Suppl; 2014 May; 91():24-31. PubMed ID: 24788997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates.
    Schwartz IS; Bach PJ; Roscoe B; Majury A; Hopman WM; Ellis E; Garrahan T; Smith J; Barkley R; Panaro L; Jamieson F; Froats C; Gemmill I; Wobeser WL
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):787-92. PubMed ID: 24902553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA; Miller TL; Stimpson JP
    Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Mathad JS; Bhosale R; Balasubramanian U; Kanade S; Mave V; Suryavanshi N; Gupte N; Joshi S; Chandanwale A; Dupnik KM; Kulkarni V; Deshpande P; Fitzgerald DW; Gupta A
    Am J Respir Crit Care Med; 2016 Jun; 193(12):1421-8. PubMed ID: 26765255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB).
    Zellweger JP; Sotgiu G; Corradi M; Durando P
    Med Lav; 2020 Jun; 111(3):170-183. PubMed ID: 32624559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
    Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
    Edathodu J; Varghese B; Alrajhi AA; Shoukri M; Nazmi A; Elgamal H; Aleid H; Alrabiah F; Ashraff A; Mahmoud I; Al-Hajoj S
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28170135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.